Detalhe da pesquisa
1.
Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis.
N Engl J Med
; 376(8): 717-728, 2017 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28225674
2.
A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease.
Vasc Med
; 24(5): 414-421, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31277561
3.
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial.
JAMA
; 320(20): 2108-2121, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30480729
4.
An Open-Label, Randomized, Single-Dose, Crossover, Comparative Pharmacokinetics Study of YLB113 and the Etanercept Reference Product in Healthy Adult Male Subjects.
Eur J Drug Metab Pharmacokinet
; 45(4): 467-475, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32172488
5.
Value of serum bilirubin levels in selecting patients for magnetic resonance cholangiopancreatography.
Hepatogastroenterology
; 54(76): 995-8, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17629024
6.
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension.
Clin Transl Allergy
; 7: 36, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29043014
7.
Clinico-radiological correlates of achalasia.
Saudi Med J
; 25(12): 1909-12, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15711665
8.
Comparison of gastric emptying parameters between asymptomatic volunteers and patients with functional dyspepsia in Middle Eastern population.
Saudi Med J
; 31(3): 270-5, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20231931